2022-09-16 | Press Launch | Shuttle Prescription drugs ($SHPH) Awarded New HDAC Inhibitor Patents for Most cancers Therapy
(TheNewswire) Shuttle Prescription drugs – TheNewswire – (SHPH), has introduced that it has been awarded patents within the U.S. and Hong Kong for its radiation sensitizing HDAC inhibitor know-how platform,…